Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MapLight Therapeutics, Inc. (MPLT) vs. Competitors

38 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MPLTMapLight Therapeutics, Inc.$7.25$402.92M-1.40-49.23%Moderate BuyUnlock the MPLT analyst price target with TipRanks PremiumMPLTUnlock the MPLT top-analyst price target with TipRanks Premium
SCNIScinai Immunotherapeutics$0.40$541.29K0.00-96.00%―Unlock the SCNI analyst price target with TipRanks PremiumMPLT vs SCNIUnlock the SCNI top-analyst price target with TipRanks Premium
GRIGRI Bio$1.70$3.72M-0.20-96.41%Moderate BuyUnlock the GRI analyst price target with TipRanks PremiumMPLT vs GRIUnlock the GRI top-analyst price target with TipRanks Premium
DRMADermata Therapeutics$0.62$3.06M-0.19-80.20%―Unlock the DRMA analyst price target with TipRanks PremiumMPLT vs DRMAUnlock the DRMA top-analyst price target with TipRanks Premium
AZTRAzitra Inc$0.61$3.69M-0.09-82.41%Moderate BuyUnlock the AZTR analyst price target with TipRanks PremiumMPLT vs AZTRUnlock the AZTR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MPLTMapLight Therapeutics, Inc.7.25-6.44-47.04%
SCNIScinai Immunotherapeutics0.40-9.22-95.84%
GRIGRI Bio1.70-43.10-96.21%
DRMADermata Therapeutics0.62-2.22-78.13%
AZTRAzitra Inc0.61-2.78-82.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts